Reducing differences in the uptake of immunisations
This is an extract from the guidance. The complete guidance is available at guidance.nice.org.uk/ph21
Appendix E: Supporting documents
Supporting documents are available online. These include the following.
-
Reviews of effectiveness:
-
'Review of the evidence of the effectiveness and cost effectiveness of interventions to address differences in the uptake of immunisations (including targeted vaccines) in people younger than 19 years'
-
'Revised analysis of the evidence of interventions to reduce differences in immunisation uptake (including targeted vaccines) in people younger than 19 years'.
-
-
Economic analysis:
-
Analysis one: 'The impact of increasing vaccine coverage on the distribution of disease: measles in the UK'
-
Analysis two: 'An exploration of the cost effectiveness of interventions to reduce the difference in uptake of childhood immunisations in the UK using threshold analysis'
-
Analysis three: 'The estimated cost effectiveness of vaccination in infants born to hepatitis B virus positive mothers'.
-
-
Fieldwork report: 'Reducing differences in the uptake of immunisations (including targeted vaccines) in children and young people aged under 19 years'.
-
A quick reference guide for professionals whose remit includes public health and for interested members of the public.
For information on how NICE public health guidance is developed, see:
-
'Methods for development of NICE public health guidance (second edition, 2009)'
-
'The NICE public health guidance development process: An overview for stakeholders including public health practitioners, policy makers and the public (second edition, 2009)'.